Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP573689.RAz0MU0g_pGyAPumCzcCnk_-3mcg1mIclnxGDvt2I-ccA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP573689.RAz0MU0g_pGyAPumCzcCnk_-3mcg1mIclnxGDvt2I-ccA130_assertion type Assertion NP573689.RAz0MU0g_pGyAPumCzcCnk_-3mcg1mIclnxGDvt2I-ccA130_head.
- NP573689.RAz0MU0g_pGyAPumCzcCnk_-3mcg1mIclnxGDvt2I-ccA130_assertion description "[The selective COX-2 inhibitor (NS398) reduced the contractile effect of serotonin in aortas from mice treated with vehicle or HS microparticles; however, this was not observed within mice treated with MetS microparticles, probably due to the ability of MetS microparticles to enhance prostacyclin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP573689.RAz0MU0g_pGyAPumCzcCnk_-3mcg1mIclnxGDvt2I-ccA130_provenance.
- NP573689.RAz0MU0g_pGyAPumCzcCnk_-3mcg1mIclnxGDvt2I-ccA130_assertion evidence source_evidence_literature NP573689.RAz0MU0g_pGyAPumCzcCnk_-3mcg1mIclnxGDvt2I-ccA130_provenance.
- NP573689.RAz0MU0g_pGyAPumCzcCnk_-3mcg1mIclnxGDvt2I-ccA130_assertion SIO_000772 22110764 NP573689.RAz0MU0g_pGyAPumCzcCnk_-3mcg1mIclnxGDvt2I-ccA130_provenance.
- NP573689.RAz0MU0g_pGyAPumCzcCnk_-3mcg1mIclnxGDvt2I-ccA130_assertion wasDerivedFrom befree-20150227 NP573689.RAz0MU0g_pGyAPumCzcCnk_-3mcg1mIclnxGDvt2I-ccA130_provenance.
- NP573689.RAz0MU0g_pGyAPumCzcCnk_-3mcg1mIclnxGDvt2I-ccA130_assertion wasGeneratedBy ECO_0000203 NP573689.RAz0MU0g_pGyAPumCzcCnk_-3mcg1mIclnxGDvt2I-ccA130_provenance.